Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microplasmin intravitreal injection for non-surgical PVD induction in diabetic macular edema
2006-004626-93Phase 2Completed
- Sponsor
- Oxurion
- Start
- Dec 2006
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ocriplasmin in diabetic macular edema (DME) (2 arms), sponsored by Oxurion. Primary endpoint: Efficacy evaluations/criteria. Started Dec 2006; status: completed.
02
Drugs
ocriplasmin
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2006-004626-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004626-93.